Clinical Trial Update: Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns [Phase 4]

View source ↗

Summary

Phase 4 study assessing the pharmacokinetics of ceftolozane/tazobactam in burn patients has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Ceftolozane/Tazobactam (ceftolozane/tazobactam)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Burns, Pharmacokinetics | Phase 4 | Status: TERMINATED | Results posted: 2021-03-02